Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Myeloma in Asia

Prof Miles Prince, Prof Kazuyuki Shimizu, Prof Jesus San Miguel
Myeloma in Asia ( Prof Miles Prince, Prof Kazuyuki Shimizu, Prof Jesus San Miguel )
6 Apr 2013

Hot topics at IMW 2013

Dr Mohamad Mohty - Nantes University Hospital, France
Hot topics at IMW 2013 ( Dr Mohamad Mohty - Nantes University Hospital, France )
5 Apr 2013

Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma

Dr Sarah Essex - University of Birmingham, UK
Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma ( Dr Sarah Essex - University of Birmingham, UK )
5 Apr 2013

Whole genome sequencing reveals underlying genetics of multiple myeloma

Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA
Whole genome sequencing reveals underlying genetics of multiple myeloma ( Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA )
4 Apr 2013

TIVO 1 study shows tivozanib an option for renal cell carcinoma

Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA
TIVO 1 study shows tivozanib an option for renal cell carcinoma ( Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA )
25 Feb 2013

A new oestrogen receptor protein target

Dr Jason Carroll – University of Cambridge, UK
A new oestrogen receptor protein target ( Dr Jason Carroll – University of Cambridge, UK )
16 Dec 2012

Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
13 Dec 2012

Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant

Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
13 Dec 2012

HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
6 Dec 2012

Targeted therapies for colorectal cancer

Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy
Targeted therapies for colorectal cancer ( Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy )
21 Nov 2012

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

Interplay between pathologies of ovarian cancer and genomics

Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation